News and Events

Find our current Cardiothoracic events and news stories below.

Never Smokers: The New Face of Lung Cancer

March 9, 2018

People often use the expression, “Where there is smoke, there is fire.” Unfortunately for lung cancer patients, the opposite is almost always assumed to be true. Where there is fire (in this case, lung cancer), it is assumed that smoking must have preceded it. This assumption often leads to the question, “Did you smoke?” following almost every personal revelation of lung cancer. Few questions engender such anger and annoyance in patients as that one, particularly in the 10%-20% of lung cancer patients who are “never smokers.”

Here is a link to the article: Never Smokers: The New Face of Lung Cancer

Refusing Surgery for Esophageal Cancer May Cause Severe Consequences for Patients

Fort Lauderdale, Florida (1/30/2018) Patients with esophageal cancer who refuse surgery when it is recommended are less likely to survive long term than similar groups of patients who undergo an operation, according to research presented today by Dr Sebron Harrison at the 54th Annual Meeting of The Society of Thoracic Surgeons.

Watch the Video

A NY Woman’s Story of Getting a New Sternum from a 3D Printer

Dr. Jeffery L. Port discusses creating a custom-made sternum using a 3D printer for a patient suffering from chronic pain following surgery to remove cancerous bone tissue.

Watch Video

Dr. Samuel J. Lang

The NewYork-Presbyterian Queens cardiovascular service line offers a full range of cardiothoracic care, providing patients in Queens with a complete local option for advanced treatment

Courtesy of MD News November 2017, Long Island Edition

Dr. Arash Salemi Featured in Health Matters

Dr. Arash Salemi, the surgical director of the Acquavella Heart Valve Center at NewYork-Presbyterian/Weill Cornell Medical Center recently featured in Health Matters discussing the role of Transcatheter Aortic Valve Replacement (TAVR).

In the article, he is quoted “The exciting things about the technology are, one, that we are able to treat a wider range of patients than we otherwise would have with just open-heart surgery. We have more options for our patients. Also, it’s less invasive physiologically than open-heart surgery. Because of that, recovery is quick. You see patients rebound and go home. They’re doing what they wanted to be doing two weeks ago. They’re doing it now without a problem. It’s very gratifying.”

Here is a link to the article: https://healthmatters.nyp.org/walk-woods-noma-bar/

CBS2’s Dr. Max Gomez shares the story of a woman who had her entire aorta replaced with a polyester version to save her life

Patients with Lung Cancer Have Risk of Cancer-Associated Suicide

Cure

By Allie Casey

June 23

Continuing coverage of Drs. Jeffrey L. Port and Mohamed Rahouma’s study, presented at the American Thoracic Society's 2017 international conference, which found that people with lung cancer have a strikingly higher-than-normal risk of suicide.

Dr. Leonard N. Girardi

Appointed to the NY State Cardiac Advisory Committee - November 2016

Appointed to the National Marfan Foundation Professional Advisory Board - December 2016

Patients Recover Faster After Robotic Heart Surgery

By Dana Arschin
December 15

Dr. T. Sloane Guy appears on FOX 5 to discuss the benefits of using robotics for heart surgery and highlights a patient who had a successful outcome. Dr. Guy does about 100 robotic heart surgeries a year and his goal is to more than double that number. He said the problem is that not enough patients know that this type of surgery exists and next spring he will be organizing a training for doctors across the country.
Dr. T. Sloane Guy, associate professor of clinical cardiothoracic surgery

Understanding Crosstalk in Tumor Microenvironment Could Lead to New Precision Medicine Approaches

Many patients with non-small cell lung cancer (NSCLC) have no identifiable mutations, and therefore their disease cannot be managed with targeted treatments. These patients often experience disease progression despite chemotherapy. However, a study led by investigators at Weill Cornell Medical Medicine used a new approach to examine crosstalk between cancer cells and cells in the microenvironment in NSCLC. Instead of looking at the tumor as a whole, the researchers used deep sequencing of RNA to analyze individual cell populations isolated from NSCLC specimens, an approach that could someday lead to new treatments for patients with NSCLC.